C16:0 CE

C16:0 CE (CAS No.: 601-34-3) is a cholesterol ester metabolite, commonly known as cholesteryl palmitate, that plays a significant role in lipid storage, transport, and membrane biology, and is widely studied in biomedical research related to pulmonary diseases and lipid metabolism disorders. As a major component of human meibum and tear film lipid layers, it contributes to the formation of stable lipid interfaces and has been utilized in studies of amphiphilic surfactants and ocular surface physiology. In respiratory research, accumulation of cholesteryl esters, including cholesteryl palmitate, in lung tissues and bronchoalveolar lavage fluid has been associated with tissue injury, inflammatory responses, and pathological remodeling, particularly in chronic interstitial pneumonia, where its levels correlate with disease progression, therapeutic response, and prognosis. Additionally, altered levels in amniotic fluid have been linked to fetal lung maturity and the risk of neonatal respiratory distress, highlighting its relevance as a biomarker in developmental and clinical contexts. Mechanistically, cholesteryl palmitate participates in lipid droplet formation and cholesterol homeostasis, indirectly influencing signaling pathways involved in inflammation, fibrosis, and cellular stress responses, although it does not act as a direct receptor ligand with defined high-affinity targets. In vitro studies typically examine its effects on lipid accumulation, macrophage activation, and epithelial cell function at micromolar concentration ranges, while in vivo investigations explore its role in disease models of lung injury and metabolic dysfunction. The concentrations or doses used in experiments typically depend on specific experimental designs and research objectives, making this compound a valuable tool for studying lipid-associated mechanisms and for biomarker discovery in chronic lung disease and related conditions.